UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer-associated financial burden in German head and neck cancer patients

Frontiers in oncology, 2024, Vol.14, p.1329242-1329242

2024

Volltextzugriff (PDF)

Malignant Vascular Tumors of the Head and Neck-Which Type of Therapy Works Best?

Cancers, 2021-12, Vol.13 (24), p.6201

2021

Volltextzugriff (PDF)

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma

International journal of cancer, 2017-06, Vol.140 (12), p.2748-2757

2017

Volltextzugriff (PDF)

Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial

Frontiers in oncology, 2019-07, Vol.9, p.625-625

2019

Volltextzugriff (PDF)

Perspectives of Induction With Chemo and/or Immune Check Point Inhibition in Head and Neck Organ Preservation Treatment

Frontiers in oncology, 2019-03, Vol.9, p.191-191

2019

Volltextzugriff (PDF)

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)

Scientific reports, 2020-05, Vol.10 (1), p.8615, Article 8615

2020

Volltextzugriff (PDF)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancers, 2021-11, Vol.13 (23), p.5890

2021

Volltextzugriff (PDF)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome

Frontiers in immunology, 2023-10, Vol.14, p.1237623-1237623

2023

Volltextzugriff (PDF)

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancers, 2021-07, Vol.13 (15), p.3781

2021

Volltextzugriff (PDF)

Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol

Frontiers in oncology, 2024-06, Vol.14, p.1394691

2024

Volltextzugriff (PDF)

Frailty and Increased Levels of Symptom Burden Can Predict the Presence of Each Other in HNSCC Patients

Journal of clinical medicine, 2023-12, Vol.13 (1), p.212

2023

Volltextzugriff (PDF)

Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies

Frontiers in oncology, 2023-12, Vol.13, p.1212454-1212454

2023

Volltextzugriff (PDF)

Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?

Cancers, 2023-06, Vol.15 (13), p.3356

2023

Volltextzugriff (PDF)

Should We De-escalate the Treatment for HPV-Positive Tumors?

HPV Infection in Head and Neck Cancer, 2017-01, Vol.206, p.173-181

2017

Volltextzugriff (PDF)

Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery

Journal of clinical medicine, 2022-08, Vol.11 (16), p.4714

2022

Volltextzugriff (PDF)

The European Larynx Organ Preservation Study [MK-3475-C44]

Frontiers in oncology, 2024-08, Vol.14

2024

Volltextzugriff (PDF)

Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group

Frontiers in oncology, 2024-08, Vol.14, p.1433333

2024

Volltextzugriff (PDF)

Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant

PloS one, 2017-06, Vol.12 (6), p.e0180354-e0180354

2017

Volltextzugriff (PDF)

Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics

Cancer chemotherapy and pharmacology, 2014-04, Vol.73 (4), p.827-837

2014

Volltextzugriff (PDF)

Obtaining Patient-Reported Outcomes Electronically With "OncoFunction" in Head and Neck Cancer Patients During Aftercare

Frontiers in oncology, 2020-11, Vol.10, p.549915-549915

2020

Volltextzugriff (PDF)

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?

Frontiers in oncology, 2021-07, Vol.11, p.715297-715297

2021

Volltextzugriff (PDF)

Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma

Journal of cancer research and clinical oncology, 2017-09, Vol.143 (9), p.1811-1814

2017

Volltextzugriff (PDF)

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker

Frontiers in oncology, 2022-02, Vol.12, p.795277-795277

2022

Volltextzugriff (PDF)

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients

Frontiers in oncology, 2021-05, Vol.11, p.682088

2021

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(114)
Deutsch
(24)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Life Sciences & Biomedicine
(93)
Humans
(65)
Oncology
(43)
Head And Neck Cancer
(32)
Female
(28)
Head And Neck Squamous Cell Carcinoma
(27)
Male
(27)
Middle Aged
(22)
Adult
(21)
Biological And Medical Sciences
(21)
Head & Neck Cancer
(20)
Squamous Cell Carcinoma
(20)
Tumors
(20)
Aged
(18)
Medical Sciences
(18)
Head And Neck Neoplasms - Pathology
(15)
Medicine
(14)
Hnscc
(12)
Human Papillomavirus
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Cancer-associated financial burden in German head and neck cancer patients

Malignant Vascular Tumors of the Head and Neck-Which Type of Therapy Works Best?

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma

Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial

Perspectives of Induction With Chemo and/or Immune Check Point Inhibition in Head and Neck Organ Preservation Treatment

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)

Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol

Frailty and Increased Levels of Symptom Burden Can Predict the Presence of Each Other in HNSCC Patients

Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies

Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?

Should We De-escalate the Treatment for HPV-Positive Tumors?

Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery

The European Larynx Organ Preservation Study [MK-3475-C44]

Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group

Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant

Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics

Obtaining Patient-Reported Outcomes Electronically With "OncoFunction" in Head and Neck Cancer Patients During Aftercare

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?

Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients

Suchergebnisse filtern